354 results on '"Khakoo, Salim I."'
Search Results
2. Using in silico models to predict lymphocyte activation and development in a data rich era
3. Trans-ancestral fine-mapping of MHC reveals key amino acids associated with spontaneous clearance of hepatitis C in HLA-DQβ1
4. A Multiancestry Sex-Stratified Genome-Wide Association Study of Spontaneous Clearance of Hepatitis C Virus
5. Testing Key Underlying Assumptions of Respondent-Driven Sampling within a Real-World Network of People Who Inject Drugs
6. Multi-ancestry fine mapping of interferon lambda and the outcome of acute hepatitis C virus infection
7. UK-Wide Multicenter Evaluation of Second-line Therapies in Primary Biliary Cholangitis
8. TOP-417 Machine learning can improve prediction of hepatitis B surface antigen seroclearance: A large multicentre cohort study in the United Kingdom
9. THU-027-YI A pilot pharmacist led carvedilol titration service leads to sustained doses of high dose carvedilol in patients with clinically significant portal hypertension
10. WED-471 Retrospective analysis of longitudinal data for UK adults living with chronic HBV: characteristics of the population on dual therapy
11. Multi-Ancestry Genome-Wide Association Study of Spontaneous Clearance of Hepatitis C Virus
12. KIR2DS2+ NK cells in cancer patients demonstrate high activation in response to tumour-targeting antibodies.
13. NK Cells in the Lymph Nodes and Their Role in Anti-Tumour Immunity.
14. MASLD and the Development of HCC: Pathogenesis and Therapeutic Challenges
15. Harnessing natural killer cell effector function against cancer
16. Targeting KIR as a novel approach to improve CAR-NK cell function
17. Impact of the COVID-19 pandemic on routine surveillance for adults with chronic hepatitis B virus (HBV) infection in the UK
18. Cattle killer immunoglobulin-like receptor expression on leukocyte subsets suggests functional divergence compared to humans.
19. Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts.
20. Activity of IL-12/15/18 primed natural killer cells against hepatocellular carcinoma
21. HLA-Bw4 80(T) and multiple HLA-Bw4 copies combined with KIR3DL1 associate with spontaneous clearance of HCV infection in people who inject drugs
22. Antiviral Responses of Tissue-resident CD49a+ Lung Natural Killer Cells Are Dysregulated in Chronic Obstructive Pulmonary Disease
23. Testing to sustain hepatitis C elimination targets in people who inject drugs: A network‐based model
24. Disruption of the NKG2A:HLA-E Immune Checkpoint Axis to Enhance NK Cell Activation against Cancer
25. Correction: Multi-ancestry fine mapping of interferon lambda and the outcome of acute hepatitis C virus infection
26. The Role of KIR in Disease
27. KIR2DS2 recognizes conserved peptides derived from viral helicases in the context of HLA-C
28. KIR2DS2 Expression Identifies NK Cells With Enhanced Anticancer Activity
29. Cohort Profile: The National Institute for Health Research Health Informatics Collaborative: Hepatitis B Virus (NIHR HIC HBV) research dataset
30. Synergistic inhibition of natural killer cells by the nonsignaling molecule CD94
31. Influence of IFNL3.rs12979860 and IFNL4.ss469415590 polymorphism on clearance of hepatitis C virus infection among Egyptians
32. Impact of the COVID-19 pandemic on routine surveillance for adults with chronic hepatitis B virus (HBV) infection in the UK
33. Peptide antagonism as a mechanism for NK cell activation
34. Selinexor Enhances NK Cell Activation Against Malignant B Cells via Downregulation of HLA-E
35. Impact of the COVID-19 pandemic on routine surveillance for adults with chronic hepatitis B virus (HBV) infection in the UK
36. Selinexor Enhances NK Cell Activation Against Lymphoma Cells Via Downregulation of HLA-E
37. OWE-6 Multicentre evaluation of second line therapies in primary biliary cholangitis: UK experience
38. PWE-16 Injecting network structure determines the most efficient strategy for Hepatitis C elimination
39. A vision of KIR variation at super resolution
40. I-COPTIC: Implementation of community pharmacy-based testing for hepatitis C: Delphi consensus protocol.
41. Activation of Natural Killer Cells During Acute Infection With Hepatitis C Virus
42. Cohort Profile: National Institute for Health Research Health Informatics Collaborative: Hepatitis B Virus (NIHR HIC HBV) Research Dataset
43. NK cells: tuned by peptide?
44. Peptide: MHC-based DNA vaccination strategy to activate natural killer cells by targeting killer cell immunoglobulin-like receptors
45. HIV-1 adaptation to NK-cell-mediated immune pressure
46. Natural Killer Cells and Regulatory T Cells Cross Talk in Hepatocellular Carcinoma: Exploring Therapeutic Options for the Next Decade
47. A DNA vaccine strategy to activate natural killer cells for therapeutic targeting of XPO1-positive tumors
48. Identifying the immune interactions underlying HLA class I disease associations
49. Prioritising Hepatitis C treatment in people with multiple injecting partners maximises prevention: A real-world network study
50. The Immune Response to HCV in Acute and Chronic Infection
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.